Differences in clinical and angiographic outcomes with different drug-eluting stents in Japanese patients with and without diabetes mellitus

Journal of Cardiology

Volumn 60, Issue 5, 2012, Pages 361-366

  Sato, Tetsuya ^a   Ono, Tamaki ^a   Morimoto, Yoshimasa ^a   Kawai, Haruaki ^a   Fuke, Soichiro ^a   Ikeda, Tetsuya ^a   Saito, Hironori ^a  

^a Okayama Red Cross Hospital   (Japan)

Author keywords

Diabetes; Drug eluting stent; Major adverse cardiac events; Prognosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGRAPHY DEVICE; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING STENT; PROGNOSIS; RECURRENT DISEASE; RESTENOSIS; SIROLIMUS ELUTING STENT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 84868609888     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.07.002     Document Type: Article

References (33)

1. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.-J., Schomig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998, 32:1866-1873.
2. Van Belle E., Perie M., Braune D., Chmait A., Meurice T., Abolmaali K., McFadden E.P., Bauters C., Lablanche J.-M., Bertrand M.E. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002, 40:410-417.
3. Takasawa Y., Iijima R., Shiba M., Nakamura M., Sugi K. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention. J Cardiol 2010, 55:391-396.
4. Settler C., Allemann S., Wandel S., Kastrati A., Morice M.C., Schomig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., Goy J., Park S.-J., Sabate M., Suttorp M., Kelbaek H., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 2008, 337:1331-1341.
5. Matsuoka H., Kawakami H., Ohshita A., Kohno T., Shigemi S., Okayama H., Higaki J. Bare metal stent implantation for in-stent restenosis with a drug-eluting stent. J Cardiol 2010, 55:135-138.
6. Spaulding C., Daemen J., Boersma E., Cutlip D.E., Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007, 356:989-997.
7. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., Cutlip D.E., Fahy M., Pocock S.J., Mehran R., Leon M.B. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356:998-1008.
8. Zhang F., Dong L., Ge J. Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus. Am J Cardiol 2010, 105:64-68.
9. Mahmud E., Bromberg-Marin G., Palakodeti V., Ang L., Creanga D., Demaria A.N. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. J Am Coll Cardiol 2008, 51:2385-2395.
10. Ellis S.G., Vandormael M.G., Cowley M.J., DiSciascio G., Deliqonul U., Topol E.J., Bulle T.M. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990, 82:1193-1202.
11. Diabetes mellitus. WHO Tech Rep Ser 1985;727:1-104.
12. Ito H., Maruyama A., Iwakura K., Takiuchi S., Masuyama T., Hori M., Higashino Y., Fujii K., Minamino T. Clinical implications of 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223-228.
13. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005, 353:663-670.
14. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., Stoll H.P. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trials: a randomized controlled trial. JAMA 2006, 295:895-904.
15. Billinger M., Beutler J., Taghetchian K.R., Remondino A., Wenaweser P., Cook S., Togni M., Seiler C., Stettler C., Eberli F.R., Luscher T.F., Wandel S., Juni P., Meier B., Windecker S. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J 2008, 29:718-725.
16. Goy J.J., Stauffer J.C., Sieganthaler M., Benoit A., Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol 2005, 45:308-311.
17. King S., Dangas G., Moses J.W. Surgery is preferred for the diabetic with multivessel disease. Circulation 2005, 112:1500-1515.
18. Popma J.J., Leon M.B., Moses J.W., Holmes D.R., Cox N., Fitzpatrick M., Douglas J., Lambert C., Mooney M., Yakubov S., Kuntz R. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004, 110:3773-3780.
19. Mauri L., Orav E.J., O'Malley A.J., Moses J.W., Leon M.B., Holmes D.R., Teirstein P.S., Schofer J., Breithardt G., Cutlip D.E., Kereiakes D., Shi C., Firth B.G., Donohoe D.J., Kuntz R.E. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 2005, 111:321-327.
20. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006, 27:260-266.
21. Kim Y.H., Park S.W., Lee S.W., Park D.W., Yun S.C., Lee C.W., Hong M.K., Kim H.S., Ko J.K., Park J.H., Lee J.H., Choi S.W., Seong I.W., Cho Y.H., Lee N.H. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 2006, 114:2148-2153.
22. Shiode N., Shirota K., Tsunoda F., Kato Y., Fujiwara M., Mimura A. Late progression after sirolimus-eluting stent implantation for de novo lesions-comparison with bare metal stent implantation. Circ J 2010, 74:1104-1110.
23. Kornowski R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Bucher T.A., Hong M.K., Popma J.J., Leon M.B. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997, 95:1366-1369.
24. Kastrati A., Dibra A., Mehilli J., Mayer S., Pinieck S., Pache J., Dirschinger J., Schömig A. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006, 113:2293-2300.
25. Togni M., Eber S., Widmer J., Billinger M., Wenaweser P., Cook S., Vogel R., Seiler C., Eberli F.R., Maier W., Corti R., Roffi M., Lüscher T.F., Garachemani A., Hess O.M., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 2007, 50:1123-1131.
26. Frobert O., Lagerqvist B., Carlsson J., Lindback J., Stenestrand U., James S.K. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus. J Am Coll Cardiol 2009, 53:1660-1667.
27. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003, 108:788-794.
28. Mauri L., Orav E.J., Kuntz R.E. Late loss in lumen diameter and binary restenosis for durg-eluting stent comparison. Circulation 2005, 111:3435-3442.
29. Kuchulakanti P.K., Chu W.W., Torguson R., Clavijo L., Wolfram R., Mishra S., Xue Z., Gevorkian N., Suddath W.O., Satler L.F., Kent K.M., Pichard A.D., Waksman R. Sirolimus-eluting stents versus paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus. Am J Cardiol 2006, 98:187-192.
30. Stettler C., Allemann S., Wandel S., Kastrati A., Morice M.C., Schömig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., Goy J.J., Park S.J., Sabaté M., Suttorp M.J., Kelbaek H., et al. Drug-eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 2008, 337:a1331.
31. Laham R.J., Carrozza J.P., Berger C., Cohen D.J., Kuntz R.E., Baim D.S. Long-term (4- to 6-year) outcome of Palmatz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol 1996, 28:820-826.
32. Soweres J.R., Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995, 26:869-879.
33. Dohi S., Kajimoto K., Miyauchi K., Yamamoto T., Tambara K., Inaba H., Kuwaki K., Tamura H., Kojima T., Yokoyama K., Kurata T., Daida H., Amano A. Comparing outcomes after off-pump coronary artery bypass versus drug-eluting stent in diabetic patients. J Cardiol 2012, 59:195-201.